Search
for
Sort by
Research 271–300 of 788
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Referee report. For: Molecular mediators involved in skin healing: a narrative review [version 1; peer review: 1 approved with reservations]
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study